Lilian Yansheng Zhou

CIK: 0002003105

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)5 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

STAA

STAAR SURGICAL CO

Director

Discretionary Trading P&L

Holdings

Transaction History (5 total)

STAA
STAAR SURGICAL CO
Jun 18, 2026
Award(A)
Restricted Stock Units
Direct
3.1K shares-
STAA
STAAR SURGICAL CO
Jun 18, 2026
Award(A)
Common Stock Options
Direct
5.6K shares-
STAA
STAAR SURGICAL CO
Jun 12, 2026
Award(A)
Direct
3.5K shares at avg. $28.29$100K
STAA
STAAR SURGICAL CO
Jun 25, 2025
Award(A)
Common Stock Options
Direct
4.4K shares-
STAA
STAAR SURGICAL CO
Jun 18, 2025
Award(A)
Common Stock Options
Direct
19.4K shares-

		Type	Shares	Price		Ownership
Jun 18, 2026	STAA STAAR SURGICAL CO	Award(A) Restricted Stock Units	3,091	-	-	Direct
Jun 18, 2026	STAA STAAR SURGICAL CO	Award(A) Common Stock Options	5,572	-	-	Direct
Jun 12, 2026	STAA STAAR SURGICAL CO	Award(A)	3,530	$28.29	$99,865	Direct
Jun 25, 2025	STAA STAAR SURGICAL CO	Award(A) Common Stock Options	4,363	-	-	Direct
Jun 18, 2025	STAA STAAR SURGICAL CO	Award(A) Common Stock Options	19,415	-	-	Direct

1-5 of 5 transactions

About Zhou Lilian Yansheng

Zhou Lilian Yansheng (SEC CIK 0002003105) files insider reports with the SEC as Director of STAAR SURGICAL CO (STAA).

Signal8 holds 4 ownership filings by Zhou Lilian Yansheng, all Form 4s, filed between Jun 20, 2025 and Jun 22, 2026. Those filings report 5 transactions, from Jun 18, 2025 to Jun 18, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Zhou Lilian Yansheng's filings is in LAKE FOREST, CA.

Recent filings by Zhou Lilian Yansheng

Jun 18, 2026: Grants or awards of STAA derivative securities (2 lines, Form 4, code A).
Jun 12, 2026: Grant or award of STAA shares (Form 4, code A).
Jun 25, 2025: Grant or award of STAA derivative securities (Form 4, code A).
Jun 18, 2025: Grant or award of STAA derivative securities (Form 4, code A).

Other insiders filing for STAAR SURGICAL CO (STAA)

ANDREWS DEBORAH J, Chief Financial Officer & EVP
Foust Warren, President and CEO
Michna Magda, Chief Development Officer
Wang Christopher Min Fang, Director
LeBuhn Richard T., Director
Bradsher Neal C, Director

How to read Form 4 transaction codes